cytarabine and Acute Relapsing Multiple Sclerosis

cytarabine has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alcalá, C; Boscá, I; Carcelén-Gadea, M; Casanova, B; Cervelló, A; Coret, F; de la Rubia, J; Gascón, F; Gil-Perotin, S; Hernández-Boluda, JC; Jarque, I; Mallada, J; Navarré, A; Pérez-Miralles, F; Sanz, J; Sanz, MA; Solano, C	1
Barnett, MH; Barnett, Y; Ford, CD; Hendrawan, K; Khoo, ML; Kyle, KA; Ma, DDF; Ma, KC; Massey, JC; Milliken, ST; Moore, JJ; Sutton, IJ; Zaunders, JJ; Zivadinov, R	1
Atlas, SW; Bollen, AW; Green, AJ; Langer-Gould, A; Pelletier, D	1

Trials

1 trial(s) available for cytarabine and Acute Relapsing Multiple Sclerosis

Article	Year
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:5 Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Progression-Free Survival; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Young Adult	2019

Article

Year

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:5

Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Progression-Free Survival; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Young Adult

2019

Other Studies

2 other study(ies) available for cytarabine and Acute Relapsing Multiple Sclerosis

Article	Year
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:7 Topics: Adult; Animals; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Rabbits; Transplantation, Autologous; Treatment Outcome	2017
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. The New England journal of medicine, 2005, Jul-28, Volume: 353, Issue:4 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aphasia; Ataxia; Brain; Cytarabine; Humans; Integrin alpha4; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Opportunistic Infections; Paresis	2005

Article

Year

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:7

Topics: Adult; Animals; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Rabbits; Transplantation, Autologous; Treatment Outcome

2017

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

The New England journal of medicine, 2005, Jul-28, Volume: 353, Issue:4

Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aphasia; Ataxia; Brain; Cytarabine; Humans; Integrin alpha4; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Opportunistic Infections; Paresis

2005